Die Entwicklung von Biomolekülen für die Grundlagenforschung und für Anwendungen in der Biotechnologie
-
Erwin-Schrödinger-Saal
Plenary
/ Panel
in englischer Sprache
| |||||
|
Ph.D. Roger Y. TSIEN
Nobel Laureate in Chemistry; Professor of Pharmacology, Chemistry and Biochemistry, University of California; Investigator, Howard Hughes Medical Institute, San Diego
1972 | Received his A.B. in Chemistry and Physics, Harvard College|
until 1981 Research Fellow, University of Cambridge | |
1977 | Ph.D. in Physiology, University of Cambridge|
1981 | First Assistant, Associate, then full Professor, University of California, Berkeley|
1989 | Investigator, Howard Hughes Medical Institute and Professor, Departments of Pharmacology and of Chemistry & Biochemistry, University of California, San Diego|
1996 | Scientific Co-founder, Aurora Biosciences Corporation, which went public in 1997|
Dr. Tsien is best known for designing and building molecules that either report or perturb signal transduction inside living cells. These molecules, created by organic synthesis or by engineering naturally fluorescent proteins, have enabled many new insights into signaling via calcium, sodium, pH, cyclic nucleotides, nitric oxide, inositol polyphosphates, membrane and redox potential changes, protein phosphorylation, active export of proteins from the nucleus, and gene transcription. He is now developing new ways to target contrast agents and therapeutic agents to tumor cells and atherosclerotic plaques based on their expression of extracellular proteases. |
Dr. Michael PRÜLLER
Stellvertretender Chefredakteur, Die Presse, Wien
1986 | Dr. juris, Paris-Lodron-Universität Salzburg
1987 | Diplomstudium, Institut Européen des Hautes Etudes Internationales, Nizza
1996-1999 | Senior Consultant, PR- und Werbeagentur Ogilvy & Mather, Wien
2000-2004 | Ressortleiter, Wirtschaftsressort ("Economist"), Tageszeitung "Die Presse"